Article Per Year (5 Year)
p-Index From 2021 - 2026
4.191
P-Index
This Author published in this journals
All Journal Journal of Food and Pharmaceutical Science Pharmaciana: Jurnal Kefarmasian Media Farmasi : Jurnal Ilmu Farmasi (Journal Of Pharmaceutical Science) Indonesian Journal of Pharmaceutical Science and Technology Majalah Obat Tradisional MPI (Media Pharmaceutica Indonesiana) JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Indonesian Journal of Chemistry JSFK (Jurnal Sains Farmasi & Klinis) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Jurnal Farmasi Sains dan Praktis Journal of Food and Pharmaceutical Sciences Medical Sains : Jurnal Ilmiah Kefarmasian Indonesian Journal of Pharmacology and Therapy Clinical and Pharmaceutical Sciences Journal
Citra Ariani Edityaningrum, Citra
Faculty Of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Education Health Professions Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Neuroscience Public Health Other

Published : 34 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 34 Documents
Search

 1   2   3   4 
Development of Self-Nano Emulsifying Drug Delivery System (SNEEDS) Containing Hibiscus sabdariffa L. extract, an Anticancer Against T47D Cells, as a co-chemotherapy of cisplatin Efiana, Nuri Ari; Nurani, Laela Hayu; Wahyuningtyas, Nurma; Edityaningrum, Citra Ariani; Indratmoko, Septiana; Guntarti, Any; Ma’ruf, Muhammad
Journal of Food and Pharmaceutical Sciences Article In Press 2026
Publisher : Integrated Research and Testing Laboratory (LPPT) Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jfps.21378

Abstract

Background: The first-line chemotherapy drug for breast cancer is cisplatin. However, it shows a high incidence of resistance. Therefore, Hibiscus Sabdariffa L (HS), containing strong anticancer compounds, was developed using a self-nano-emulsifying drug delivery system (SNEDDS), potentially as cisplatin co-chemotherapy. This study aimed to develop the HS SNEDDS providing anticancer activity against T47D breast cancer cells. Methods: Development of HS SNEDDS (F1-F7) with various surfactant and co-surfactant concentrations was carried out, followed by characterization of HS SNEDDS. The selected formulation was performed regarding the cytotoxicity on T47D cells and selectivity on Vero cells. Results: F7 as a selected formulation indicated a transmittance, globule size, PI, zeta potential, and emulsification time of 97.80%, 15.68 ± 0.19 nm, 0.12 ± 0.01, -8.05 ± 1.88 mV, and 24.76 ± 0.29 seconds, respectively. Furthermore, the IC50 of HS extract, HS SNEDDS, and Cisplatin on T47D cells were 0.37 ± 0.02, 0.24 ± 0.02, and 0.01 ± 0.001 mg/mL The selectivity index (SI) of HS SNEDDS and cisplatin were 108101.25 and 8351.84, respectively. Conclusion: HS SNEDDS providing the required characteristics could be obtained, and potentially be used as a co-chemotherapy of cisplatin, showing the cytotoxic effect on T47D breast cancer cells.
Development of Self-Nano Emulsifying Drug Delivery System (SNEEDS) Containing Hibiscus sabdariffa L. extract, an Anticancer Against T47D Cells, as a co-chemotherapy of cisplatin Efiana, Nuri Ari; Nurani, Laela Hayu; Wahyuningtyas, Nurma; Edityaningrum, Citra Ariani; Indratmoko, Septiana; Guntarti, Any; Ma’ruf, Muhammad
Journal of Food and Pharmaceutical Sciences Article In Press 2026
Publisher : Integrated Research and Testing Laboratory (LPPT) Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jfps.21378

Abstract

Background: The first-line chemotherapy drug for breast cancer is cisplatin. However, it shows a high incidence of resistance. Therefore, Hibiscus Sabdariffa L (HS), containing strong anticancer compounds, was developed using a self-nano-emulsifying drug delivery system (SNEDDS), potentially as cisplatin co-chemotherapy. This study aimed to develop the HS SNEDDS providing anticancer activity against T47D breast cancer cells. Methods: Development of HS SNEDDS (F1-F7) with various surfactant and co-surfactant concentrations was carried out, followed by characterization of HS SNEDDS. The selected formulation was performed regarding the cytotoxicity on T47D cells and selectivity on Vero cells. Results: F7 as a selected formulation indicated a transmittance, globule size, PI, zeta potential, and emulsification time of 97.80%, 15.68 ± 0.19 nm, 0.12 ± 0.01, -8.05 ± 1.88 mV, and 24.76 ± 0.29 seconds, respectively. Furthermore, the IC50 of HS extract, HS SNEDDS, and Cisplatin on T47D cells were 0.37 ± 0.02, 0.24 ± 0.02, and 0.01 ± 0.001 mg/mL The selectivity index (SI) of HS SNEDDS and cisplatin were 108101.25 and 8351.84, respectively. Conclusion: HS SNEDDS providing the required characteristics could be obtained, and potentially be used as a co-chemotherapy of cisplatin, showing the cytotoxic effect on T47D breast cancer cells.
Development of Self-Nano Emulsifying Drug Delivery System (SNEEDS) Containing Hibiscus sabdariffa L. Extract, an Anticancer against T47D Cells, as a Co-Chemotherapy of Cisplatin Nurani, Laela Hayu; Efiana, Nuri Ari; Wahyuningtyas, Nurma; Edityaningrum, Citra Ariani; Indratmoko, Septiana; Guntarti, Any; Ma’ruf, Muhammad
Journal of Food and Pharmaceutical Sciences Vol 14, No 1 (2026): J.Food.Pharm.Sci
Publisher : Integrated Research and Testing Laboratory (LPPT) Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jfps.21378

Abstract

The first-line chemotherapy drug for breast cancer is cisplatin. However, it shows a high incidence of resistance. Therefore, Hibiscus Sabdariffa L (HS), containing strong anticancer compounds, was developed using a self-nano-emulsifying drug delivery system (SNEDDS), potentially as cisplatin co-chemotherapy. This study aimed to develop the HS SNEDDS providing anticancer activity against T47D breast cancer cells. The methods consist of the development of HS SNEDDS (F1-F7) with various surfactant and co-surfactant concentrations, followed by characterization of HS SNEDDS. The selected formulation was evaluated regarding the cytotoxicity on T47D cells and selectivity on Vero cells. The results showed that F7, as a selected formulation, indicated a transmittance, globule size, PI, zeta potential, and emulsification time of 97.80%, 15.68 ± 0.19 nm, 0.12 ± 0.01, -8.05 ± 1.88 mV, and 24.76 ± 0.29 seconds, respectively. Furthermore, according to the data of toxicity and selectivity studies, HS SNEDDS was proven to enhance the toxic properties of HS extract on T47D cells and be safe on normal cells. In conclusion, HS SNEDDS providing the required characteristics could be obtained, and potentially be used as a co-chemotherapy of cisplatin, showing the cytotoxic effect on T47D breast cancer cells.
Development of Self-Nano Emulsifying Drug Delivery System (SNEEDS) Containing Hibiscus sabdariffa L. Extract, an Anticancer against T47D Cells, as a Co-Chemotherapy of Cisplatin Nurani, Laela Hayu; Efiana, Nuri Ari; Wahyuningtyas, Nurma; Edityaningrum, Citra Ariani; Indratmoko, Septiana; Guntarti, Any; Ma’ruf, Muhammad
Journal of Food and Pharmaceutical Sciences Vol 14, No 1 (2026): J.Food.Pharm.Sci
Publisher : Integrated Research and Testing Laboratory (LPPT) Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jfps.21378

Abstract

The first-line chemotherapy drug for breast cancer is cisplatin. However, it shows a high incidence of resistance. Therefore, Hibiscus Sabdariffa L (HS), containing strong anticancer compounds, was developed using a self-nano-emulsifying drug delivery system (SNEDDS), potentially as cisplatin co-chemotherapy. This study aimed to develop the HS SNEDDS providing anticancer activity against T47D breast cancer cells. The methods consist of the development of HS SNEDDS (F1-F7) with various surfactant and co-surfactant concentrations, followed by characterization of HS SNEDDS. The selected formulation was evaluated regarding the cytotoxicity on T47D cells and selectivity on Vero cells. The results showed that F7, as a selected formulation, indicated a transmittance, globule size, PI, zeta potential, and emulsification time of 97.80%, 15.68 ± 0.19 nm, 0.12 ± 0.01, -8.05 ± 1.88 mV, and 24.76 ± 0.29 seconds, respectively. Furthermore, according to the data of toxicity and selectivity studies, HS SNEDDS was proven to enhance the toxic properties of HS extract on T47D cells and be safe on normal cells. In conclusion, HS SNEDDS providing the required characteristics could be obtained, and potentially be used as a co-chemotherapy of cisplatin, showing the cytotoxic effect on T47D breast cancer cells.
Co-Authors Abdul Rohman Agitohutomo, Muhammad Aisyah, Vani Akrom, Akrom Aldri Frinaldi Anggita Rosiana Putri Anjar Windarsih Annas Binarjo Any Guntarti Any Guntarti Any Guntarti Arimurni, Dewa Ayu Aristiani, Windi Aristiani, Windy Ariza Nur Zulaechah Artika Tri Oktafiani Azizah, Siwi Nur Azzahra, Fara Daud, Intan Dian Prasasti Dwi Utami Efiana, Nuri Ari Endah Prastyaningrum Feby Zulien Hardi Astuti Witasari HENI RACHMAWATI Hidayati, Sholihatil Ibnu Gholib Gandjar Ibnu Gholib Gandjar Ichsan Luqmana Indra Putra, Ichsan Luqmana Indra Ichwan Ridwan Rais Irfan, Nawwar Irnawati Irnawati Khairun Nisa Khairurrizki, Amanda Khayatulisma, Dika Kintoko, Kintoko Laela Hayu Nurani Lalu Muhammad Irham Lina Widiyastuti Maulida, Khansa Syahira Ma’ruf, Muhammad Milanie, Rida Dwi Moch Saiful Bachri Moch. Saiful Bachri Monika, Tika Muhammad Ma'ruf Muhammad Yusron Maulana El-Yunusi Niken Pratiwi, Niken Nina Salamah Nisa, Salsabila Naura Nur Ismiyati Prastyaningrum, Endah Putri, Cintana Violena Alifia Rini Sulistyawati Rizki Amelia Siti Fatmawati Fatimah, Siti Fatmawati Siti Rofida Sri Mulyaningsih Ste, Luay Banna Sugiyanto - Sulistyorini, Dwi Agustin Tantri Sofia Fauziah Tika Monika Tika Monika, Tika Utari, Dina Vani Aisyah Wahyuningtyas, Nurma Widea Rossi Desvita Widiyastuti, Lina Widyasari Putranti Wihasty Nur Istyqomah Zahirah, Nadrah Adinda Zainab Zainab